RNA-focused digital therapeutics company Flamingo Therapeutics added a new member to its board of directors, Dr. Ezra Cohen.
Flamingo produces RNA therapies for oncology and is backed by investors such as Andera Partners, Bpifrance Large Venture, Perceptive Advisors, Sphera and VIB.
Dr. Cohen has a history in the development of pharmaceuticals, especially head and neck cancers.
"The science...
Life sciences software company Synthace has raised $35 million (€30.6M) in Series C funding to expand the reach of its research and development (R&D) cloud platform, where scientists can record and share their research and insights.
The R&D-focused, no-code software platform enables scientists to share, view and access progress with cures and therapeutics in one place, making it simpler...
